SARS-CoV-2 vertical transmission during the first trimester of pregnancy in asymptomatic womenArticle Published on 2022-11-012022-11-16 Journal: International Journal of Infectious Diseases [Category] SARS, 치료기술, [키워드] Asymptomatic collected consequence detrimental evaluate fetal fetus first trimester increased risk investigated management occur Pregnancy pregnant women reported SARS-CoV-2 SARS-CoV-2 RNA detection SARS-CoV-2 transmission specimen spread to syncytiotrophoblast Transmission vertical transmission Vertical transmission. Viremia women [DOI] 10.1016/j.ijid.2022.09.020 PMC 바로가기
The first case of meningitis associated with SARS-CoV-2 BA.2 variant infection with persistent viremiaArticle Published on 2022-11-012022-11-16 Journal: International Journal of Infectious Diseases [Category] SARS, 변종, [키워드] Blood barrier damage COVID-19 described diagnosed disease event female Infection Meningitis Neurological disorder omicron Omicron. Patient SARS-CoV-2 the SARS-CoV-2 variant Vascular Viremia [DOI] 10.1016/j.ijid.2022.09.011 PMC 바로가기
Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature ReviewArticle Published on 2022-09-252022-11-15 Journal: International Journal of Molecular Sciences [Category] 진단, [키워드] Abnormalities acute kidney Acute kidney injury Affect association Atypical Atypical hemolytic uremic syndrome causes clinically Cohort comparable complement Coronavirus disease 2019 Corticosteroid COVID-19 deviation digestive disorder Frequency Genetic individuals inhibitor initial Injury kidney literature majority mild respiratory symptom occurred outcome pathogenic Patient patients plasma purpura renal review Seven specific treatment survival Symptom therapy thrombotic thrombotic microangiopathy Thrombotic thrombocytopenic purpura. treated uremic uremic syndrome viral clearance Viremia with COVID-19 [DOI] 10.3390/ijms231911307 PMC 바로가기
Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)Article Published on 2022-09-212022-11-15 Journal: BMC Infectious Diseases [Category] SARS, 진단, 치료기술, [키워드] age analyzed anti-SARS-CoV-2 Anti-spike Antiretroviral therapy black BNT162b2 booster CD4 CD8 cells clinically COVID-19 COVID-19 vaccination COVID-19 vaccine decrease demographics detectable dose exploratory female HIV Humoral immunity IgG IgG levels immune response immunogenicity majority male marker median MOST occurred offered Older outcome participant positive presenting primary analysis protective immunity quantitative assessment reactogenicity recruited responses SARS-CoV-2 SARS-CoV-2. secondary single-center Spike protein subject suppressed T-cell T-cell Response vaccination Viremia virus-specific T-cell response white Wilcoxon signed-rank test with HIV [DOI] 10.1186/s12879-022-07737-0 PMC 바로가기
Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19Article Published on 2022-09-142022-11-15 Journal: Journal of Virology [Category] SARS, 치료기술, 치료제, [키워드] Activation amplified amplify analyzed blocked Blood Cell chemokine chronic liver disease Chronic Liver Diseases circulating comorbid disease Comorbidity contribute controls correlated COVID-19 COVID-19 patients Critical cytokine cytokine secretion DCLK1 DDCLK1 decrease disease severity dysregulation expression Factor Factors Gain growth factor hospitalized patient Host Hyperinflammatory response immune Immune cell immune response immunosuppressive in viral in vitro infected cells Inflammation Inflammatory cytokine inflammatory pathway inhibition inhibitor Innate immunity involved kinase Live virus liver livers loss of function lung Lung disease Macrophage mononuclear cell mononuclear cells Mortality neutrophil normalized Pathogenesis pathology Patient Peripheral blood potential therapeutic target Prevalence pro-inflammatory profile proinflammatory promoted promoter Protein S100A9 SARS-CoV-2 SARS-CoV-2-infected cell secretion severity of COVID-19 Signaling subject targeting Treatment Viremia virus production virus replication Virus replication. with COVID-19 β-catenin [DOI] 10.1128/jvi.00967-22 PMC 바로가기
The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemiaArticle Published on 2022-08-302022-11-15 Journal: mBio [Category] COVID19(2023년), SARS, 진단, [키워드] accelerated antibody baseline binding binding activity binding antibody Characteristics clearance COVID-19 COVID-19 disease COVID-19 disease severity Critical death defined development disease disease severity dissemination effective Evolution examined FcγR feature function highlight humoral humoral immune response IgG IgG3 immune immune clearance immune function Immune profile independent Kinetics Longitudinal data longitudinal data modeling maturation monoclonal Mortality natural infection neutralization outcome persistence persistent persistent SARS-CoV-2 plasma viremia plasma predict progression provide SARS-CoV-2 SARS-CoV-2 replication severe COVID-19 Specificities subunit system serology viral clearance viral replication Viremia viremia. [DOI] 10.1128/mbio.01577-22 PMC 바로가기
High Monocyte Count Associated with Human Cytomegalovirus Replication In Vivo and Glucocorticoid Therapy May Be a Hallmark of DiseaseArticle Published on 2022-08-242022-11-16 Journal: International Journal of Molecular Sciences [Category] 치료기술, [키워드] caused CD14 Characteristics clinical model/translational medicine clinical response Clinical symptoms CMV comparable correlated corticosteroid therapy count COVID-19 cytomegalovirus cytomegalovirus (CMV) kinetics decrease defined definitions of cytomegalovirus disease described Dexamethasone disease dose glucocorticoid growth hallmark healthy subjects homogeneous homogeneous sample of subjects logarithmic phase of infection Human Increased Infection Infectious disease innate immune innate immune response investigated leukopenia lymphopenia macrophages molecular monocyte monocytes characteristics and analysis monocytosis mononucleosis neutropenia observation onset of fever pathogen detection Patient prodrome Replication Sample Significant steroid subject syndrome tested the median viral infection Viral load viral replication Viremia virome virus virus replication Virus replication. [DOI] 10.3390/ijms23179595 PMC 바로가기
Correlation of clinical characteristics between patients with seasonal influenza and patients infected by the wild type or delta variant of SARS-CoV-2Article Published on 2022-08-182022-11-16 Journal: Frontiers in Public Health [Category] SARS, 변종, [키워드] acute respiratory syndrome alleviate Antibiotics antiviral drug bacterial co-infection Biomarker Clinical characteristics Cohort cohorts Comorbidity connection coronavirus correlation COVID-19 COVID-19 cohort COVID-19 pandemic COVID-19 vaccines delta variant demonstrated disease onset flu greater hematological parameters hospital hospital discharge Hospitalization immunization impairment individual Influenza information laboratory data male median age Mild mild cases Myocardial Patient patients with COVID-19 patients with influenza recovery. remained renal SARS-CoV-2 Seasonal influenza the patient Treatment variant variant of SARS-CoV-2 viral disease Viremia wild type wild-type with COVID-19 [DOI] 10.3389/fpubh.2022.981233 PMC 바로가기
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbitsrVSV-ΔG-SARS-CoV-2-S 백신: NZW 토끼에서 반복되는 근육내(IM) 독성, 국소 내성, 면역원성 및 생체 분포 연구Article Published on 2022-08-012022-09-11 Journal: Archives of Toxicology [Category] COVID19(2023년), MERS, SARS, 비임상, 진단, 치료기술, [키워드] Administered animals antibody antibody levels Antibody titers Antigen assigned binding biodistribution biodistribution study body temperature body weight breath C-reactive protein change Clinical pathology Clinical signs clinical trial clinical trials correlated COVID-19 detection elicited evaluate Express followed by Gross High-dose high-dose group histopathological iliac lymph node immunogenicity inflammatory reaction injection intervals intramuscular intramuscularly Local local reactions Lymph node mesenteric lymph nodes Necrosis Neutralizing antibodies Neutralizing antibody titer neutralizing antibody titers New Nonclinical ophthalmology pathology Phase 2 platform Reactions repeated RNA Safe Safety SARS-CoV-2 SARS-CoV-2-S significant increase spleen stomatitis supported systemic the vaccine Tolerance Toxicity two group two groups Urinalysis vaccination Vaccine vaccine doses vaccine. Vector-based vaccine vesicular stomatitis vesicular stomatitis virus Viremia VSV was performed [DOI] 10.1007/s00204-022-03302-5 PMC 바로가기 [Article Type] Article
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 SeverityCOVID-19 중증도 결정을 위한 혈청 SARS-CoV-2 항원Article Published on 2022-07-282022-09-11 Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Antigen antigenic Antigenic assay Chemiluminescent assay CLIA COVID-19 COVID-19 diagnosis Determination diagnostic disease severity evaluate false-negative false-negative results followed by help intensive care Kinetics likelihood ratio marker N antigen nasopharyngeal non-severe patient non-severe patients onset of symptoms Patient performed polymerase chain reaction polymerase chain reactions positive Prognosis prognosis test. progression provided reverse transcriptase risk RT-PCR RT-PCRs SARS-CoV-2 SARS-COV-2 infection sensitive serum severe and non-severe patients severe COVID-19 severe patients severity Simoa swabs the WHO threshold transcriptase Viremia was determined were measured WHO Clinical Progression Scale [DOI] 10.3390/v14081653 PMC 바로가기 [Article Type] Article